Literature DB >> 15367533

Fatal fulminant myocarditis caused by disseminated mucormycosis.

A Basti1, S Taylor, M Tschopp, J Sztajzel.   

Abstract

Acute fulminant myocarditis is a critical clinical condition with sudden onset of severe congestive heart failure followed by severe haemodynamic deterioration. Instituting early left ventricular support may improve outcome and result in better long term survival. The case of an immunocompromised patient who developed acute fulminant myocarditis in the setting of disseminated mucormycosis is presented.

Entities:  

Mesh：

Year:  2004        PMID： 15367533      PMCID： PMC1768475          DOI： 10.1136/hrt.2004.038273

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  7 in total

Review 1.  Myocarditis.

Authors:  A M Feldman; D McNamara
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

2.  National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee).

Authors:  Naoyoshi Aoyama; Tohru Izumi; Katsuhiko Hiramori; Mitsuaki Isobe; Masatoshi Kawana; Michiaki Hiroe; Hitoshi Hishida; Yasushi Kitaura; Tsutomu Imaizumi
Journal:  Circ J       Date:  2002-02       Impact factor: 2.993

Review 3.  Two cases of disseminated mucormycosis in patients with hematological malignancies and literature review.

Authors:  I Cuvelier; D Vogelaers; R Peleman; D Benoit; V Van Marck; F Offner; K Vandewoude; F Colardyn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-12       Impact factor: 3.267

4.  Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.

Authors:  R E McCarthy; J P Boehmer; R H Hruban; G M Hutchins; E K Kasper; J M Hare; K L Baughman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

5.  Echocardiographic findings in fulminant and acute myocarditis.

Authors:  G M Felker; J P Boehmer; R H Hruban; G M Hutchins; E K Kasper; K L Baughman; J M Hare
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

Review 6.  Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor.

Authors:  C E Gonzalez; D R Couriel; T J Walsh
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

7.  Management of acute fulminant myocarditis using circulatory support systems.

Authors:  N Reiss; A el-Banayosy; H Posival; M Morshuis; K Minami; R Körfer
Journal:  Artif Organs       Date:  1996-08       Impact factor: 3.094
  7 in total
  3 in total

Review 1.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

2.  The rise of an opportunistic infection called "Invasive Zygomycosis".

Authors:  Abdelkarim Waness; Ghuzayel Al Dawsari; Hamdan Al Jahdali
Journal:  J Glob Infect Dis       Date:  2009-07

3.  Acute Cardiac Failure due to Intra-Atrial Mass Caused by Zygomycetes in an Immunocompromised Paediatric Patient.

Authors:  G J van de Glind; C E M Gidding; C M W Verlaat; K Duthoi; A P C Backx; P E Verweij; A Warris
Journal:  Case Rep Med       Date:  2010-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.